×
Back to Agenda
Meeting in the Middle: Best Practices for Collaboration Between Medical Affairs and Clinical Development
Session Chair(s)
J. Lynn Bass
Medical Affairs Lead, Mesoblast, Inc, United States
Medical affairs and clinical development enhance the scientific credibility of the company (and its products) with established and emerging clinical investigators These collaborations may also improve study recruitment techniques.
Learning Objective : Design new activities which require participation from both medical affairs and clinical development; Demonstrate how the medical affairs team can provide real-world data to help inform study designs and execution; Critique case studies of successful collaborations.
Speaker(s)
Industry Update
Medical Affairs Lead, Mesoblast, Inc, United States
Industry Update
Vice President, Global Patient Networks | PD Medical Affairs, Genentech, A Member of the Roche Group, United States
Industry Update
, Mesoblast, United States
Have an account?